Equities

Pulmonx Corp

Pulmonx Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)6.79
  • Today's Change0.37 / 5.76%
  • Shares traded293.97k
  • 1 Year change-35.94%
  • Beta0.6916
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments117141180
Total Receivables, Net139.286.92
Total Inventory171516
Prepaid expenses2.823.454.17
Other current assets, total0.740.520.58
Total current assets150169208
Property, plant & equipment, net7.431113
Goodwill, net2.332.332.33
Intangibles, net0.030.150.28
Long term investments145.9211
Note receivable - long term------
Other long term assets3.175.810.73
Total assets178194235
LIABILITIES
Accounts payable1.501.761.58
Accrued expenses191614
Notes payable/short-term debt000
Current portion long-term debt/capital leases2.160.090.09
Other current liabilities, total0.660.661.53
Total current liabilities231818
Total long term debt351717
Total debt371717
Deferred income tax0.110.090.04
Minority interest------
Other liabilities, total1.113.857.02
Total liabilities594042
SHAREHOLDERS EQUITY
Common stock0.040.040.04
Additional paid-in capital527503483
Retained earnings (accumulated deficit)(411)(350)(291)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total2.641.581.71
Total equity118154193
Total liabilities & shareholders' equity178194235
Total common shares outstanding393837
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.